A detailed history of Quadrant Capital Group LLC transactions in Viatris Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,862 shares of VTRS stock, worth $19,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,862
Previous 1,894 1.69%
Holding current value
$19,979
Previous $20,000 5.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$10.32 - $12.13 $330 - $388
-32 Reduced 1.69%
1,862 $21,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $540 - $649
48 Added 2.6%
1,894 $22,000
Q4 2023

Feb 08, 2024

SELL
$8.77 - $10.85 $11,883 - $14,701
-1,355 Reduced 42.33%
1,846 $19,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $3,193 - $3,779
333 Added 11.61%
3,201 $31,000
Q2 2023

Aug 09, 2023

BUY
$9.02 - $10.29 $5,123 - $5,844
568 Added 24.7%
2,868 $28,000
Q1 2023

May 11, 2023

BUY
$9.2 - $12.26 $1,278 - $1,704
139 Added 6.43%
2,300 $22,000
Q4 2022

Feb 10, 2023

SELL
$8.72 - $11.56 $8,554 - $11,340
-981 Reduced 31.22%
2,161 $24,000
Q3 2022

Nov 10, 2022

SELL
$8.48 - $11.13 $3,553 - $4,663
-419 Reduced 11.77%
3,142 $27,000
Q2 2022

Aug 09, 2022

SELL
$9.95 - $12.27 $1,074 - $1,325
-108 Reduced 2.94%
3,561 $37,000
Q1 2022

May 06, 2022

SELL
$9.81 - $15.4 $1,049 - $1,647
-107 Reduced 2.83%
3,669 $40,000
Q4 2021

Feb 01, 2022

BUY
$12.09 - $14.68 $7,133 - $8,661
590 Added 18.52%
3,776 $51,000
Q3 2021

Nov 12, 2021

BUY
$13.25 - $15.13 $1,192 - $1,361
90 Added 2.91%
3,186 $43,000
Q2 2021

Aug 09, 2021

SELL
$12.97 - $16.15 $24,500 - $30,507
-1,889 Reduced 37.89%
3,096 $44,000
Q1 2021

May 12, 2021

SELL
$13.59 - $18.54 $5,748 - $7,842
-423 Reduced 7.82%
4,985 $70,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $77,334 - $101,345
5,408 New
5,408 $101,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.